Sofosbuvir and Velpatasvir: A complete pan-genotypic treatment for HCV patients

Most read articles by the same author(s)

• Harleen Chela, Bhupinder S. Romana, Markandeya Madabattula, Abdulmajeed A. Albarrak, Mohamad H. Yousef, Sami Samiullah, Veysel Tahan, Stem cell therapy: a potential for the perils of pancreatitis , Turkish Journal of Gastroenterology: Vol. 31 No. 6 (2020): Turkish Journal of Gastroenterology
• Veysel Tahan, How will I know whether “an apple is ripe or rotten”? A new proposed composite algorithm to predict acute liver failure in patients with drug-induced liver injury , Turkish Journal of Gastroenterology: Vol. 25 No. 3 (2014): Turkish Journal of Gastroenterology
• Jessica Nguyen Winn, Veysel Tahan, In a world of increasing resistance emerges a hope to eradicate Helicobacter pylori: Vonoprazan , Turkish Journal of Gastroenterology: Vol. 27 No. 3 (2016): Turkish Journal of Gastroenterology
• Ali Murat Kahveci, Veysel Tahan, Daclatasvir plus sofosbuvir regimen sheds promising light on future hepatitis C virus genotype 3 therapies , Turkish Journal of Gastroenterology: Vol. 27 No. 1 (2016): Turkish Journal of Gastroenterology
• Anjana Sathyamurthy, Veysel Tahan, “Are we ready to change our colorectal cancer screening practice?” Traditional serrated adenomas or serrated adenomas with dysplasia should be regarded as advanced adenomas with high grade dysplasia , Turkish Journal of Gastroenterology: Vol. 27 No. 5 (2016): Turkish Journal of Gastroenterology
• Veysel Tahan, Once spontaneous bacterial peritonitis develops, discontinue nonselective beta blockers permanently. A proposed practice change update , Turkish Journal of Gastroenterology: Vol. 25 No. 2 (2014): Turkish Journal of Gastroenterology